Showing results (351-360 of 360) with videos related to
Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 360 results.
International Journal of Cardiology|February 8, 2026
Microvascular vasomotor dysfunction is more prevalent in female versus epicardial vasomotor dysfunction in male ANOCA patientsJ Woudstra, A C Dimitriu-Leen, C Crooijmans, et al.ESMO Open|December 3, 2025
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trialJ Capdevila, S Tafuto, M Krogh, et al.European Journal of Cancer (Oxford, England : 1990)|May 28, 2026
The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysisJ C M Scheepens, K J Prinsze, L G van Geest, et al.Circulation. Cardiovascular Interventions|March 29, 2026
Diagnostic Yield and Safety of Invasive Coronary Function Testing After Radial Versus Femoral AccessFleur W Adriaansen, Caïa Crooijmans, Tijn P J Jansen, et al.JAMA Cardiology|February 19, 2025
Safety, Feasibility, and Diagnostic Yield of Invasive Coronary Function Testing: Netherlands Registry of Invasive Coronary Vasomotor Function TestingCaïa Crooijmans, Tijn P J Jansen, Joan G Meeder, et al.BMC Cancer|August 7, 2023
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trialJ L van Dam, E M M Verkolf, E N Dekker, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 28, 2025
Timing of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: A nationwide analysisP C M Andel, I W J M van Goor, N C Biesma, et al.Trials|April 30, 2021
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialM S Walma, S J Rombouts, L J H Brada, et al.BMC Cancer|February 19, 2025
Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocolT F Stoop, L W F Seelen, F R van 't Land, et al.Trials|April 18, 2020
Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trialT M Mackay, F J Smits, A E J Latenstein, et al.Pageof 36